Cargando…

International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials

The Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody – Vaccine Immune Monitoring Consortium (CAVD/CA-VIMC) assisted an international network of laboratories in transferring a validated assay used to judge HIV-1 vaccine immunogenicity in compliance with Good Clinical Laboratory Practic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozaki, Daniel A., Gao, Hongmei, Todd, Christopher A., Greene, Kelli M., Montefiori, David C., Sarzotti-Kelsoe, Marcella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267749/ https://www.ncbi.nlm.nih.gov/pubmed/22303476 http://dx.doi.org/10.1371/journal.pone.0030963

Ejemplares similares

Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL)
por: Todd, Christopher A., et al.
Publicado: (2013)

P15-04. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells
por: Todd, CA, et al.
Publicado: (2009)

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials
por: Sarzotti-Kelsoe, M, et al.
Publicado: (2009)

Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy
por: Hu, Xintao, et al.
Publicado: (2017)

Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells
por: Sarzotti-Kelsoe, M, et al.
Publicado: (2012)

Validated low-volume aldosterone immunoassay tailored to GCLP-compliant investigations in small sample volumes
por: Schaefer, J., et al.
Publicado: (2017)

Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs
por: Seaman, Michael S., et al.
Publicado: (2020)

Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies
por: Bharadwaj, Pranay, et al.
Publicado: (2020)

LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays
por: Piehler, Britt, et al.
Publicado: (2011)

Validation of an automated system for aliquoting of HIV-1 Env-pseudotyped virus stocks
por: Schultz, Anke, et al.
Publicado: (2018)

Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV
por: Brown, Eric P., et al.
Publicado: (2018)

An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials
por: Schultz, Anke, et al.
Publicado: (2012)

Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
por: Wesley, Martina S., et al.
Publicado: (2021)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2018)

Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens
por: Dennison, S. Moses, et al.
Publicado: (2018)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
por: Kelsoe, Garnett, et al.
Publicado: (2013)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

P06-07. A GCLP accredited Clinical Trial Laboratory Network in Africa and India: a collaborative effort between IAVI and in country research organizations
por: Stevens, G, et al.
Publicado: (2009)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
por: Lacerda, Miguel, et al.
Publicado: (2013)

Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments
por: Hraber, Peter, et al.
Publicado: (2017)

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
por: Wagh, Kshitij, et al.
Publicado: (2016)

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
por: Bajic, Goran, et al.
Publicado: (2019)

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
por: Fournier, Carole, et al.
Publicado: (2007)

Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials
por: Sarzotti-Kelsoe, Marcella, et al.
Publicado: (2009)

International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
por: Fenyö, Eva Maria, et al.
Publicado: (2009)

International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II
por: Heyndrickx, Leo, et al.
Publicado: (2012)

Development of a high-throughput assay to measure measles neutralizing antibodies
por: Alvarado-Facundo, Esmeralda, et al.
Publicado: (2019)

Analytical and clinical performance of cPass neutralizing antibodies assay
por: Jung, Joanna, et al.
Publicado: (2021)

Rapid AAV-Neutralizing Antibody Determination with a Cell-Binding Assay
por: Guo, Ping, et al.
Publicado: (2018)

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Detection of HIV-1 Neutralizing Antibodies in a Human CD4(+)/CXCR4(+)/CCR5(+) T-Lymphoblastoid Cell Assay System
por: McLinden, Robert J., et al.
Publicado: (2013)

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
por: Rosenberg, Yvonne, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_418fu77mjbnq5pqoodmqg62cls